Clinical outcomes of conduction system pacing compared to biventricular pacing in patients requiring cardiac resynchronization therapy

医学 心脏再同步化治疗 射血分数 内科学 危险系数 心脏病学 心力衰竭 左束支阻滞 QRS波群 临床终点 束支阻滞 置信区间 心电图 随机对照试验
作者
Pugazhendhi Vijayaraman,Dipen Zalavadia,Abdul Haseeb,Cicely Dye,Nidhi Madan,Jamario Skeete,Sharath C. Vipparthy,W. Glenn Young,Venkatesh Ravi,Clement Rajakumar,Parash Pokharel,Timothy R. Larsen,Henry D. Huang,Randle Storm,Jess W. Oren,Syeda Atiqa Batul,Richard G. Trohman,Faiz A. Subzposh,Parikshit S. Sharma
出处
期刊:Heart Rhythm [Elsevier BV]
卷期号:19 (8): 1263-1271 被引量:132
标识
DOI:10.1016/j.hrthm.2022.04.023
摘要

Background Cardiac resynchronization therapy (CRT) with biventricular pacing (BVP) is well-established therapy in patients with reduced left ventricular ejection fraction (LVEF) and bundle branch block or indication for pacing. Conduction system pacing (CSP) using His-bundle pacing (HBP) or left bundle branch area pacing (LBBAP) has been shown to be a safe and more physiological alternative to BVP. Objective The purpose of this study was to compare the clinical outcomes between CSP and BVP among patients undergoing CRT. Methods This observational study included consecutive patients with LVEF ≤35% and class I or II indications for CRT who underwent successful BVP or CSP at 2 major health care systems. The primary outcome was the composite endpoint of time to death or heart failure hospitalization (HFH). Secondary outcomes included subgroup analysis in left bundle branch block as well as individual endpoints of death and HFH. Results A total of 477 patients (32% female) met inclusion criteria (BVP 219; CSP 258 [HBP 87, LBBAP 171]). Mean age was 72 ± 12 years, and mean LVEF was 26% ± 6%. Comorbidities included hypertension 70%, diabetes mellitus 45%, and coronary artery disease 52%. Paced QRS duration in CSP was significantly narrower than BVP (133 ± 21 ms vs 153 ± 24 ms; P <.001). LVEF improved in both groups during mean follow-up of 27 ± 12 months and was greater after CSP compared to BVP (39.7% ± 13% vs 33.1% ± 12%; P <.001). Primary outcome of death or HFH was significantly lower with CSP vs BVP (28.3% vs 38.4%; hazard ratio 1.52; 95% confidence interval 1.082–2.087; P = .013). Conclusion CSP improved clinical outcomes compared to BVP in this large cohort of patients with indications for CRT. Cardiac resynchronization therapy (CRT) with biventricular pacing (BVP) is well-established therapy in patients with reduced left ventricular ejection fraction (LVEF) and bundle branch block or indication for pacing. Conduction system pacing (CSP) using His-bundle pacing (HBP) or left bundle branch area pacing (LBBAP) has been shown to be a safe and more physiological alternative to BVP. The purpose of this study was to compare the clinical outcomes between CSP and BVP among patients undergoing CRT. This observational study included consecutive patients with LVEF ≤35% and class I or II indications for CRT who underwent successful BVP or CSP at 2 major health care systems. The primary outcome was the composite endpoint of time to death or heart failure hospitalization (HFH). Secondary outcomes included subgroup analysis in left bundle branch block as well as individual endpoints of death and HFH. A total of 477 patients (32% female) met inclusion criteria (BVP 219; CSP 258 [HBP 87, LBBAP 171]). Mean age was 72 ± 12 years, and mean LVEF was 26% ± 6%. Comorbidities included hypertension 70%, diabetes mellitus 45%, and coronary artery disease 52%. Paced QRS duration in CSP was significantly narrower than BVP (133 ± 21 ms vs 153 ± 24 ms; P <.001). LVEF improved in both groups during mean follow-up of 27 ± 12 months and was greater after CSP compared to BVP (39.7% ± 13% vs 33.1% ± 12%; P <.001). Primary outcome of death or HFH was significantly lower with CSP vs BVP (28.3% vs 38.4%; hazard ratio 1.52; 95% confidence interval 1.082–2.087; P = .013). CSP improved clinical outcomes compared to BVP in this large cohort of patients with indications for CRT.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
pluto的应助被Euuuuuun采纳,获得10
刚刚
科研通AI6.4的应助被008采纳,获得10
1秒前
Xiao完成签到 ,获得积分10
1秒前
qiuranran完成签到,获得积分20
1秒前
2秒前
mikeboying完成签到,获得积分10
3秒前
SHIPEIYU完成签到 ,获得积分10
3秒前
4秒前
吱吱发布了新的文献求助10
5秒前
和平发展发布了新的文献求助10
5秒前
酷酷飞烟完成签到,获得积分10
5秒前
6秒前
6秒前
科研通AI6.4的应助被娇妹儿采纳,获得10
6秒前
wangchiyi发布了新的文献求助10
7秒前
7秒前
8秒前
8秒前
勤奋一一的应助被yy采纳,获得10
9秒前
chocolate完成签到 ,获得积分10
9秒前
BANLAN完成签到,获得积分10
9秒前
如意的泽完成签到 ,获得积分10
9秒前
kento发布了新的文献求助50
10秒前
11秒前
YunjiangZhang发布了新的文献求助10
11秒前
大个的应助被cc采纳,获得10
11秒前
陶醉从云发布了新的文献求助10
11秒前
12秒前
fzw发布了新的文献求助10
12秒前
Zeroracex发布了新的文献求助10
12秒前
陈谨诺发布了新的文献求助10
12秒前
okleba关注了科研通微信公众号
13秒前
13秒前
13秒前
远远完成签到 ,获得积分10
14秒前
14秒前
14秒前
14秒前
mrwow完成签到 ,获得积分10
14秒前
zwhy579完成签到 ,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8171039
求助须知:如何正确求助?哪些是违规求助? 9563751
关于积分的说明 21772122
捐赠科研通 7762548
什么是DOI,文献DOI怎么找? 3430786
关于科研通互助平台的介绍 2554676
邀请新用户注册赠送积分活动 2475657